psoriasis psoriatic arthritis arthritis psoriatica artritis psoriatica psoriatic artritis
Conditions
Interventions
None
Sponsors
Radboudumc
Eligibility
Inclusion criteria
Inclusion criteria: * Diagnosis of cutaneous psoriasis * Age 18 years or above * Willing and able to comply with visits and study-related procedures * Provide signed informed consent (IC)
Exclusion criteria
Exclusion criteria: * Age below 18 years * Unable to give IC * Unable or unwilling to comply with visits and study-related procedures * Participation in other trials involving psoriatic disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The prevalence of (newly discovered) PsA in known PsO patients in the setting of a university dermatology outpatient clinic, in total and stratified per treatment group | — |
Secondary
| Measure | Time frame |
|---|---|
| - The prevalence of complaints in the various domains of PsA in the newly discovered PsA patients - The predictive value of joint complaints for the presence of PsA in PsO - The predictive value of cutaneous parameters of PsO for the presence of PsA - The predictive value of comorbidity for the presence of PsA in PsO - The predictive value of entheseal/joint injury for the presence of PsA in PsO - The predictive value of laboratory markers for the presence of PsA in PsO - The predictive value of genetic markers for the presence of PsA in PsO - The effect of referral to a rheumatology department on different disease domains and QoL | — |
Contacts
Public ContactTamara van Hal
Sint Maartenskliniek
Outcome results
None listed